---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-007836"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T01:54:03.989124+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Elite launches generic Percocet (oxycodone/acetaminophen) tablets in 3 strengths

## Summary
- Launched generic oxycodone HCl/acetaminophen tablets in 5/325, 7.5/325, and 10/325 mg strengths.
- Product is indicated for moderate to moderately severe pain, marketed under Elite Laboratories label.
- IQVIA reported 2024 brand sales of ~$317 million for the reference product.

## SEC filing metadata
- accession: 0001641172-25-007836
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000164117225007836/0001641172-25-007836-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000164117225007836/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-007836
- JSON: https://secwatch.observer/filing/0001641172-25-007836.json
- Plain text: https://secwatch.observer/filing/0001641172-25-007836.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.